{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T05:04:24Z","timestamp":1755925464168},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":2805,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1038\/mt.2008.242","type":"journal-article","created":{"date-parts":[[2008,11,11]],"date-time":"2008-11-11T15:05:18Z","timestamp":1226415918000},"page":"373-379","source":"Crossref","is-referenced-by-count":17,"title":["Genetic Vaccines for Anthrax Based on Recombinant Adeno-associated Virus Vectors"],"prefix":"10.1016","volume":"17","author":[{"given":"Te-Hui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Oscherwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Schnepp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemp B","family":"Cease","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip R","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2008.242_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ijmm.2007.09.007","article-title":"Bacillus anthracis: balancing innocent research with dual-use potential","volume":"298","author":"Hudson","year":"2008","journal-title":"Int J Med Microbiol"},{"key":"10.1038\/mt.2008.242_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"Collier","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1038\/mt.2008.242_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mib.2003.12.001","article-title":"The roles of anthrax toxin in pathogenesis","volume":"7","author":"Moayeri","year":"2004","journal-title":"Curr Opin Microbiol"},{"key":"10.1038\/mt.2008.242_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"Dixon","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2008.242_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00189414","article-title":"Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity","volume":"177","author":"Turnbull","year":"1988","journal-title":"Med Microbiol Immunol"},{"key":"10.1038\/mt.2008.242_bib6","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/IAI.63.4.1369-1372.1995","article-title":"Protective immunity induced by Bacillus anthracis toxin-deficient strains","volume":"63","author":"Pezard","year":"1995","journal-title":"Infect Immun"},{"key":"10.1038\/mt.2008.242_bib7","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","article-title":"Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein","volume":"69","author":"Price","year":"2001","journal-title":"Infect Immun"},{"key":"10.1038\/mt.2008.242_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/CVI.00321-07","article-title":"Role of vaccine-induced antibodies to anthrax lethal and edema toxin","volume":"15","author":"Taft","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1038\/mt.2008.242_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1164\/rccm.200608-1239CP","article-title":"Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy","volume":"175","author":"Sherer","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1038\/mt.2008.242_bib10","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1086\/510856","article-title":"Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model","volume":"195","author":"Cui","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2008.242_bib11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/JB.85.1.230-236.1963","article-title":"Studies on immunity in anthrax. X Gel-adsorbed protective antigen for immunization of man","volume":"85","author":"Puziss","year":"1963","journal-title":"J Bacteriol"},{"key":"10.1038\/mt.2008.242_bib12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"key":"10.1038\/mt.2008.242_bib13","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1038\/mt.2008.242_bib14","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"Fellows","year":"2001","journal-title":"Vaccine"},{"key":"10.1038\/mt.2008.242_bib15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2105\/AJPH.52.4.632","article-title":"Field evaluation of a human anthrax vaccine","volume":"52","author":"Brachman","year":"1962","journal-title":"Am J Public Health Nations Health"},{"key":"10.1038\/mt.2008.242_bib16","first-page":"75180","article-title":"Biological products; bacterial vaccines and toxoids; implementation of efficacy review; anthrax vaccine adsorbed; final order","volume":"70","author":"FDA","year":"2005","journal-title":"Fed Regist"},{"key":"10.1038\/mt.2008.242_bib17","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0264-410X(98)00023-1","article-title":"The effectiveness and safety of vaccines against human anthrax: a systematic review","volume":"16","author":"Demicheli","year":"1998","journal-title":"Vaccine"},{"key":"10.1038\/mt.2008.242_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/pds.712","article-title":"Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"11","author":"Sever","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1038\/mt.2008.242_bib19","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0264-410X(01)00462-5","article-title":"Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans","volume":"20","author":"Pittman","year":"2002","journal-title":"Vaccine"},{"key":"10.1038\/mt.2008.242_bib20","series-title":"The Anthrax Vaccine: Is it safe? Does it work?","author":"Joellenbeck","year":"2002"},{"key":"10.1038\/mt.2008.242_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1566523034578285","article-title":"From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy","volume":"3","author":"Grimm","year":"2003","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2008.242_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2174\/1566523034578131","article-title":"Evaluation of risks related to the use of adeno-associated virus-based vectors","volume":"3","author":"Tenenbaum","year":"2003","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2008.242_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1743-422X-4-99","article-title":"The state of the art of adeno-associated virus-based vectors in gene therapy","volume":"4","author":"Coura Rdos","year":"2007","journal-title":"Virol J"},{"key":"10.1038\/mt.2008.242_bib24","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.1128\/JVI.71.10.7960-7962.1997","article-title":"Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D","volume":"71","author":"Manning","year":"1997","journal-title":"J Virol"},{"key":"10.1038\/mt.2008.242_bib25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1006\/mthe.2000.0132","article-title":"Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines","volume":"2","author":"Liu","year":"2000","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.242_bib26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1128\/JVI.79.2.955-965.2005","article-title":"Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques","volume":"79","author":"Johnson","year":"2005","journal-title":"J Virol"},{"key":"10.1038\/mt.2008.242_bib27","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1128\/JVI.80.6.2621-2630.2006","article-title":"Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1","volume":"80","author":"Kuck","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/mt.2008.242_bib28","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1073\/pnas.88.2.478","article-title":"Heterologous introns can enhance expression of transgenes in mice","volume":"88","author":"Palmiter","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.242_bib29","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1074\/jbc.M109997200","article-title":"Mapping the anthrax protective antigen binding site on the lethal and edema factors","volume":"277","author":"Lacy","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2008.242_bib30","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1128\/JVI.70.5.3227-3234.1996","article-title":"Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors","volume":"70","author":"Ferrari","year":"1996","journal-title":"J Virol"},{"key":"10.1038\/mt.2008.242_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/clim.1999.4724","article-title":"Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration","volume":"92","author":"Brockstedt","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1038\/mt.2008.242_bib32","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/104303401750214276","article-title":"A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus","volume":"12","author":"Xin","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2008.242_bib33","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1089\/10430340260201662","article-title":"Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses","volume":"13","author":"Xin","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2008.242_bib34","doi-asserted-by":"crossref","first-page":"11899","DOI":"10.1128\/JVI.00890-06","article-title":"Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells","volume":"80","author":"Xin","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/mt.2008.242_bib35","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.vaccine.2006.09.072","article-title":"AAV vectors encoding malarial antigens stimulate antigen-specific immunity but do not protect from parasite infection","volume":"25","author":"Logan","year":"2007","journal-title":"Vaccine"},{"key":"10.1038\/mt.2008.242_bib36","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/gt.2008.68","article-title":"Clinical gene therapy using recombinant adeno-associated virus vectors","volume":"15","author":"Mueller","year":"2008","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2008.242_bib37","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4049\/jimmunol.180.2.948","volume":"180","author":"Du","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/mt.2008.242_bib38","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.vaccine.2004.06.048","article-title":"DNA and low titer, helper-free, recombinant AAV prime-boost vaccination for cytomegalovirus induces an immune response to CMV-pp65 and CMV-IE1 in transgenic HLA A*0201 mice","volume":"23","author":"Gallez-Hawkins","year":"2004","journal-title":"Vaccine"},{"key":"10.1038\/mt.2008.242_bib39","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/IAI.65.12.5171-5175.1997","article-title":"Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs","volume":"65","author":"Little","year":"1997","journal-title":"Infect Immun"},{"key":"10.1038\/mt.2008.242_bib40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2672.1999.00897.x","article-title":"In vitro correlate of immunity in an animal model of inhalational anthrax","volume":"87","author":"Pitt","year":"1999","journal-title":"J Appl Microbiol"},{"key":"10.1038\/mt.2008.242_bib41","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1073\/pnas.0405557101","article-title":"A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores","volume":"101","author":"Hermanson","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.242_bib42","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/CVI.00402-07","article-title":"Detoxified lethal toxin as a potential mucosal vaccine against anthrax","volume":"15","author":"Xu","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1038\/mt.2008.242_bib43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(98)00210-2","article-title":"Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen","volume":"17","author":"Gu","year":"1999","journal-title":"Vaccine"},{"key":"10.1038\/mt.2008.242_bib44","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.vaccine.2003.09.043","article-title":"Genetic immunization against anthrax","volume":"22","author":"Galloway","year":"2004","journal-title":"Vaccine"},{"key":"10.1038\/mt.2008.242_bib45","first-page":"1124","article-title":"A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors","volume":"3","author":"Clark","year":"1996","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2008.242_bib46","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1089\/hum.1995.6.10-1329","article-title":"Cell lines for the production of recombinant adeno-associated virus","volume":"6","author":"Clark","year":"1995","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2008.242_bib47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JVI.76.2.791-801.2002","article-title":"Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity","volume":"76","author":"Rabinowitz","year":"2002","journal-title":"J Virol"},{"key":"10.1038\/mt.2008.242_bib48","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/10430349950018427","article-title":"Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses","volume":"10","author":"Clark","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2008.242_bib49","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1128\/JVI.77.6.3495-3504.2003","article-title":"Genetic fate of recombinant adeno-associated virus vector genomes in muscle","volume":"77","author":"Schnepp","year":"2003","journal-title":"J Virol"},{"key":"10.1038\/mt.2008.242_bib50","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1016\/j.vaccine.2005.10.046","article-title":"Low-dose intraperitoneal Freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide","volume":"24","author":"Oscherwitz","year":"2006","journal-title":"Vaccine"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616315167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616315167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T04:01:22Z","timestamp":1589083282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616315167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S1525001616315167"],"URL":"https:\/\/doi.org\/10.1038\/mt.2008.242","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}